5608 Results

People

  1. Motzer
    Motzer
  2. Scher
    Scher
  3. Solit
    Solit
  4. Morris
    Morris
  5. Bajorin
    Bajorin
  6. Rosenberg
    Rosenberg
  7. Berger
    Berger
  8. Iyer
    Iyer
  9. Reuter
    Reuter
  10. Feldman
    Feldman

Groups

  1. Genitourinary Oncology Service (5608)
  2. Solid Tumor Oncology Division (5608)
  3. Department of Medicine (5598)
  4. GSK Faculty (1640)
  5. Human Oncology and Pathogenesis Program (1139)
  6. Department of Pathology and Laboratory Medicine (1034)
  7. Surgery (1000)
  8. Epidemiology and Biostatistics (864)
  9. Survivorship Research (773)
  10. Urology (769)
  1. "Genitourinary Oncology Service"
Formats
  1. Journal Article (2745)
  2. Meeting Abstract (2507)
  3. Review (113)
  4. Book Section (82)
  5. Editorial (52)
  6. Correspondence (33)
  7. Conference Paper (29)
  8. Guidelines (24)
  9. Research Letter (15)
  10. Book Whole (4)
  11. Miscellaneous (4)
Groups
  1. Genitourinary Oncology Service (5608)
  2. Solid Tumor Oncology Division (5608)
  3. Department of Medicine (5598)
  4. GSK Faculty (1640)
  5. Human Oncology and Pathogenesis Program (1139)
  6. Department of Pathology and Laboratory Medicine (1034)

More Groups

People
  1. Robert Motzer (1243)
  2. Howard Scher (1130)
  3. David Solit (779)
  4. Dean Bajorin (657)
  5. Michael Morris (577)
  6. Jonathan Rosenberg (510)

More People

Years
  1. 2025 (118)
  2. 2024 (293)
  3. 2023 (283)
  4. 2022 (314)
  5. 2021 (341)
  6. 2020 (352)

More Years

Publications
  1. Journal of Clinical Oncology (1697)
  2. Annals of Oncology (303)
  3. Clinical Cancer Research (282)
  4. Cancer Research (245)
  5. Cancer (125)
  6. European Urology (118)

More Publications

Publishers
  1. American Society of Clinical Oncology (1757)
  2. American Association for Cancer Research (688)
  3. Oxford University Press (408)
  4. Elsevier Science, Inc. (389)
  5. Elsevier Inc. (384)
  6. Nature Publishing Group (294)

More Publishers

Results (5608)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II trial of sunitinib in patients with metastatic non-clear cell renal cell carcinoma
    Journal Article

    Molina, A. M.; Feldman, D. R.; Ginsberg, M. S.; Kroog, G.; Tickoo, S. K.; Jia, X.; Georges, M.; Patil, S.; Baum, M. S.; Reuter, V. E.; more...
    Investigational New Drugs (2012)

    Fulltext@MSK | Save
  • Induction of cutaneous squamous cell carcinomas by RAF inhibitors: Cause for concern?
    Journal Article

    Lacouture, M. E.; O'reilly, K.; Rosen, N.; Solit, D. B.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Progression-free and overall survival in patients with relapsed/refractory germ cell tumors treated with single-agent chemotherapy: Endpoints for clinical trial design
    Journal Article

    Feldman, D. R.; Patil, S.; Trinos, M. J.; Carousso, M.; Ginsberg, M. S.; Sheinfeld, J.; Bajorin, D. F.; Bosl, G. J.; Motzer, R. J.
    Cancer (2012)

    Fulltext@MSK | Save
  • Prostate cancer in 2011: Hitting old targets better and identifying new targets
    Journal Article

    Chen, Y.; Scher, H. I.
    Nature Reviews Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Everolimus in metastatic renal cell carcinoma: Subgroup analysis of patients with 1 or 2 previous vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapies enrolled in the phase III RECORD-1 study
    Journal Article

    Calvo, E.; Escudier, B.; Motzer, R. J.; Oudard, S.; Hutson, T. E.; Porta, C.; Bracarda, S.; Grünwald, V.; Thompson, J. A.; Ravaud, A.; more...
    European Journal of Cancer (2012)

    Fulltext@MSK | Save
  • Biomarkers in the management and treatment of men with metastatic castration-resistant prostate cancer
    Journal Article

    Armstrong, A. J.; Eisenberger, M. A.; Halabi, S.; Oudard, S.; Nanus, D. M.; Petrylak, D. P.; Sartor, A. O.; Scher, H. I.
    European Urology (2012)

    Fulltext@MSK | Save
  • Clinical impact of residual extraretroperitoneal masses in patients with advanced nonseminomatous germ cell testicular cancer
    Journal Article

    Masterson, T. A.; Shayegan, B.; Carver, B. S.; Bajorin, D. F.; Feldman, D. R.; Motzer, R. J.; Bosl, G. J.; Sheinfeld, J.
    Urology (2012)

    Fulltext@MSK | Save
  • Tumor metabolism and perfusion in head and neck squamous cell carcinoma: Pretreatment multimodality imaging with (1)H magnetic resonance spectroscopy, dynamic contrast-enhanced MRI, and [(18)F]FDG-PET
    Journal Article

    Jansen, J. F. A.; Schoder, H.; Lee, N. Y.; Stambuk, H. E.; Wang, Y.; Fury, M. G.; Patel, S. G.; Pfister, D. G.; Shah, J. P.; Koutcher, J. A.; more...
    International Journal of Radiation Oncology, Biology, Physics (2012)

    Fulltext@MSK | Save
  • Prostate cancer
    Book Section

    Chen, Y.; Arora, V. K.; Sawyers, C. L.
    In DeVita, V. T. Jr; Lawrence, T. S.; Rosenberg, S. A. (Eds.) Cancer: Principles & Practice of Oncology: Primer of the Molecular Biology of Cancer. 1st ed (2011)

    Fulltext@MSK | Save
  • Evaluation of circulating tumor cell (CTC) enumeration as an efficacy response biomarker of overall survival (OS) in metastatic castration-resistant prostate cancer (mCRPC): Planned final analysis (FA) of COU-AA-301, a randomized, double-blind, placebo-controlled, phase III study of abiraterone acetate (AA) plus low-dose prednisone (P) post docetaxel
    Meeting Abstract

    Scher, H. I.; Heller, G.; Molina, A.; Kheoh, T. S.; Attard, G.; Moreira, J.; Sandhu, S. K.; Parker, C.; Logothetis, C.; McCormack, R. T.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save